2Martini, Disclaimer: I'm NOT a novice to all of t

2Martini, Disclaimer: I'm NOT a novice to all of this, i.e. public stock investment and pharma. I agree that DJL is qualified from the medical/research side, but is he assertive enough to push back, respectfully (starting with 700mg, for example instead of 350mg in trials. There appears to be gobs of safety data to support, are there not)? We need aggressive persuasion. I spent plenty of time earning 56 hours of biology, 21 hours of chemistry, and 12 hours of physics, and I can tell you that "sales and marketing" is NOT TAUGHT in those classrooms. I agree with your proof of concept assertion as the science appears to be there, but that means bigger trials (which will be expensive, but I am willing to make that a priority and buck up for that....either the science is there or it is not. Let's make it definitive with more data!!!), AND faster enrolling trials (hire "boots on the ground" to promote enrollment in enrollment site cities. As mentioned in a prior post, I have seen it done before. This is no government job where the work will always be there tomorrow to complete, this is a race against MUCH bigger, deeper-pocketed, politically-connected, business savvy, big pharma players. Time is our enemy!